👀 Copy Legendary Investors' Portfolios in One ClickCopy For Free

Insider trades & hedge fund moves: Carl Icahn tosses out Illumina chair

Published 2023-05-30, 03:44 a/m
© Reuters.
GM
-
ILMN
-
EVGO
-
DNA
-

By Davit Kirakosyan

Here is your Pro Recap of the biggest insider trades and hedge fund actions you may have missed this week: news out of Carl Icahn and Illumina, and top brass buys at General Motors, Ginkgo Bioworks, and EVgo.

InvestingPro subscribers got these headlines in real time. Start your 7-day free trial.

Illumina board chair voted out, but CEO survives vote

Illumina (NASDAQ:ILMN) shares plunged nearly 9% on Thursday after activist investor Carl Icahn successfully ousted Illumina's board chairman, John Thompson, with shareholder support, while his efforts to remove the company’s CEO Francis deSouza from the board failed, surviving the vote.

Icahn's board nominees Vincent Intrieri and Jesse Lynn failed to secure enough votes. Shareholders voted for one of Icahn's three nominees, Andrew Teno, to join Illumina's board. The company plans to select a new chair in the coming weeks.

InvestingPro | Know Market Moves

General Motors CFO purchases $1 million in stock

General Motors (NYSE:GM) CFO Paul Jacobson bought 31,000 shares, or worth over $1 million, at $32.60, as InvestingPro reported in real time.

Last month, the company reported its Q1 earnings, with EPS of $2.21 and revenue of $40 billion beating the Street estimates. Following the announcement, the company earned upgrades from two Wall Street firms. Morgan Stanley upgraded the company to Overweight from Equalweight and raised its price target to $38.00 from $35.00. Meanwhile, CFRA upgraded the company to Hold from Sell and raised its price target to $35.00 from $31.00.

Two Ginkgo Bioworks directors buy nearly $1M in stock

Ginkgo Bioworks (NYSE:DNA) saw large insider buys from two directors. Harry Sloan purchased 350,000 shares and Shyam Sankar bought 400,000 shares at $1.28, for a total value of $960,000.

Earlier this month, the company reported its Q1 earnings, missing on EPS but revenue beat the consensus estimates. Following the results, William Blair downgraded the company to Market Perform from Outperform.

EVgo director buys $25M in stock

EVgo (NASDAQ:EVGO) Director David Nanus bought 5,882,352 shares, or worth about $25 million, at $4.25. Following the filing, shares gained 3% after-hours on Wednesday but retreated almost to breakeven in the next regular session.

Get a leg up on the market: Always be the first to know with InvestingPro.

Start your free 7-day trial now.

InvestingPro | Be The First To Know

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.